Morocco Launches First Cannabis-Based Epilepsy Drug

Morocco Launches First Cannabis-Based Epilepsy Drug
Source: Mugglehead Investment Magazine

In a breakthrough for those suffering from epilepsy in Morocco, Pharma 5 has launched the first-ever generic drug made from cannabis to treat epilepsy. Pharma 5 has invested $25 million to develop the first made-in-Morocco cannabidiol (CBD). Given that the generic drug "Epidyolex" costs over $1,000, it is a significant step forward reducing Morocco’s reliance on expensive imported drugs.

Great! You’ve successfully signed up.

Welcome back! You've successfully signed in.

You've successfully subscribed to MAGHREB INSIDER.

Success! Check your email for magic link to sign-in.

Success! Your billing info has been updated.

Your billing was not updated.